References
- Edelman D, Olsen MK, Dudley TK, et al. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2010;19:1175–80
- Blüher M. The distinction of metabolically ‘healthy' from ‘unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38–43
- Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013;14:219–27
- Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring) 2013;21:203–9
- Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013;36:2388–94
- Velho S, Paccaud F, Waeber G, et al. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010;64:1043–51
- Saudek CD, Derr RL, Kalvani RR. Assessing glycaemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006;295:1688–97
- American Diabetes Association. Standards of medical care of diabetes. Diabetes Care 2007;30:S4–41
- Furukawa N, Araki E. Type 2 diabetes and impaired glucose tolerance. Nihon Rinsho 2013;71:270–4
- Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 2004;66:S37–43
- Muneyuki T, Suwa K, Oshida H, et al. Design of the Saitama Cardiometabolic Disease and Organ Impairment Study (SCDOIS): a multidisciplinary observational epidemiological study. Open J Endocr Metab Dis 2013;2:144–56
- Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187–91
- Nathan DM, Kuenen J, Borg R, et al. A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473–8
- WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63
- Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig 2012;3:39–40
- American Diabetes Association. Standards of medical care in diabetes – 2013. Diabetes Care 2013;35:S11–66
- Waki K, Noda M, Sasaki S, et al. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabet Med 2005;22:323–31
- Thomas C, Hyppönen E, Power C. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 2006;166:682–8
- Heianza Y, Arase Y, Hsieh SD, et al. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6). Diabetologia 2012;55:3213–23
- Blaha MJ, Gebretsadik T, Shintani A, Elasy TA. Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes. Obesity (Silver Spring) 2008;16:869–74